Michelle Renee Griffin, Director at Adaptive Biotechnologies Corp (ADPT), sold 2,500 shares at $38.56 ($96K) on 2021-06-14, disclosed to the SEC on 2021-06-16.
Open-market sale of $96k ADPT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ADPT | SELL | 2026-03-05 | $735K | — | Filing → |
| ADPT | SELL | 2025-03-17 | $522K | — | Filing → |
| ADPT | SELL | 2025-03-06 | $249K | — | Filing → |